Ionis Pharmaceuticals | IONS - Выручка от реализации

Биржевая цена
74.20
Изменение за день
-1.48 -1.96%
Ежемесячно
-1.41%
Ежегодный
121.10%
Q2 прогноз
74.14




Продажи Изменить Дата
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Arrowhead Research USD 73.74M 190.29M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
Celltrion KRW 1.15T 180B 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 389M 289M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 13.11B 226M 2026-03
OPKO Health USD 148.45M 3.22M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Pharma Mar EUR 42.9M 47.3M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tilray USD 217.51M 74.75M 2025-12
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03